BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28273136)

  • 1. DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy.
    Shadle SC; Zhong JW; Campbell AE; Conerly ML; Jagannathan S; Wong CJ; Morello TD; van der Maarel SM; Tapscott SJ
    PLoS Genet; 2017 Mar; 13(3):e1006658. PubMed ID: 28273136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DUX4-induced bidirectional HSATII satellite repeat transcripts form intranuclear double-stranded RNA foci in human cell models of FSHD.
    Shadle SC; Bennett SR; Wong CJ; Karreman NA; Campbell AE; van der Maarel SM; Bass BL; Tapscott SJ
    Hum Mol Genet; 2019 Dec; 28(23):3997-4011. PubMed ID: 31630170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy.
    Bosnakovski D; Gearhart MD; Toso EA; Recht OO; Cucak A; Jain AK; Barton MC; Kyba M
    Dis Model Mech; 2017 Oct; 10(10):1211-1216. PubMed ID: 28754837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients.
    Dmitriev P; Bou Saada Y; Dib C; Ansseau E; Barat A; Hamade A; Dessen P; Robert T; Lazar V; Louzada RAN; Dupuy C; Zakharova V; Carnac G; Lipinski M; Vassetzky YS
    Free Radic Biol Med; 2016 Oct; 99():244-258. PubMed ID: 27519269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy.
    Feng Q; Snider L; Jagannathan S; Tawil R; van der Maarel SM; Tapscott SJ; Bradley RK
    Elife; 2015 Jan; 4():. PubMed ID: 25564732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei.
    Vanderplanck C; Tassin A; Ansseau E; Charron S; Wauters A; Lancelot C; Vancutsem K; Laoudj-Chenivesse D; Belayew A; Coppée F
    Skelet Muscle; 2018 Jan; 8(1):2. PubMed ID: 29329560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells.
    Jagannathan S; Shadle SC; Resnick R; Snider L; Tawil RN; van der Maarel SM; Bradley RK; Tapscott SJ
    Hum Mol Genet; 2016 Oct; 25(20):4419-4431. PubMed ID: 28171552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.
    Oliva J; Galasinski S; Richey A; Campbell AE; Meyers MJ; Modi N; Zhong JW; Tawil R; Tapscott SJ; Sverdrup FM
    J Pharmacol Exp Ther; 2019 Aug; 370(2):219-230. PubMed ID: 31189728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein.
    Kowaljow V; Marcowycz A; Ansseau E; Conde CB; Sauvage S; Mattéotti C; Arias C; Corona ED; Nuñez NG; Leo O; Wattiez R; Figlewicz D; Laoudj-Chenivesse D; Belayew A; Coppée F; Rosa AL
    Neuromuscul Disord; 2007 Aug; 17(8):611-23. PubMed ID: 17588759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle.
    Yao Z; Snider L; Balog J; Lemmers RJ; Van Der Maarel SM; Tawil R; Tapscott SJ
    Hum Mol Genet; 2014 Oct; 23(20):5342-52. PubMed ID: 24861551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?
    Tassin A; Laoudj-Chenivesse D; Vanderplanck C; Barro M; Charron S; Ansseau E; Chen YW; Mercier J; Coppée F; Belayew A
    J Cell Mol Med; 2013 Jan; 17(1):76-89. PubMed ID: 23206257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis.
    Young JM; Whiddon JL; Yao Z; Kasinathan B; Snider L; Geng LN; Balog J; Tawil R; van der Maarel SM; Tapscott SJ
    PLoS Genet; 2013 Nov; 9(11):e1003947. PubMed ID: 24278031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the hyaluronic acid pathway as a therapeutic target for facioscapulohumeral muscular dystrophy.
    DeSimone AM; Leszyk J; Wagner K; Emerson CP
    Sci Adv; 2019 Dec; 5(12):eaaw7099. PubMed ID: 31844661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of DUX4 gene regulation and its implication for facioscapulohumeral muscular dystrophy.
    Jagannathan S
    Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166367. PubMed ID: 35158020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FSHD atrophic myotube phenotype is caused by DUX4 expression.
    Vanderplanck C; Ansseau E; Charron S; Stricwant N; Tassin A; Laoudj-Chenivesse D; Wilton SD; Coppée F; Belayew A
    PLoS One; 2011; 6(10):e26820. PubMed ID: 22053214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle.
    Banerji CRS; Panamarova M; Hebaishi H; White RB; Relaix F; Severini S; Zammit PS
    Nat Commun; 2017 Dec; 8(1):2152. PubMed ID: 29255294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of epigenetic silencing of the DUX4 transcription factor gene in facioscapulohumeral muscular dystrophy.
    Hewitt JE
    Hum Mol Genet; 2015 Oct; 24(R1):R17-23. PubMed ID: 26113644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity.
    Jones TI; Chew GL; Barraza-Flores P; Schreier S; Ramirez M; Wuebbles RD; Burkin DJ; Bradley RK; Jones PL
    Skelet Muscle; 2020 Apr; 10(1):8. PubMed ID: 32278354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy.
    Geng LN; Yao Z; Snider L; Fong AP; Cech JN; Young JM; van der Maarel SM; Ruzzo WL; Gentleman RC; Tawil R; Tapscott SJ
    Dev Cell; 2012 Jan; 22(1):38-51. PubMed ID: 22209328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear bodies reorganize during myogenesis in vitro and are differentially disrupted by expression of FSHD-associated DUX4.
    Homma S; Beermann ML; Yu B; Boyce FM; Miller JB
    Skelet Muscle; 2016 Dec; 6(1):42. PubMed ID: 27906075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.